An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Top Cited Papers
- 15 August 2019
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 381 (7), 603-613
- https://doi.org/10.1056/nejmoa1902226
Abstract
Type 1 diabetes is a chronic autoimmune disease that leads to destruction of insulin-producing beta cells and dependence on exogenous insulin for survival. Some interventions have delayed the loss of insulin production in patients with type 1 diabetes, but interventions that might affect clinical progression before diagnosis are needed.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK061010, U01 DK061034, U01 DK061042, U01 DK061058, U01 DK085461, U01 DK085465, U01 DK085466, U01 DK085476, U01 DK085499, U01 DK085509, U01 DK103266, U01 DK103282, U01 DK106984, U01 DK107013, U01 DK107014, UC4 DK085466, UC4 DK097835, UC4 DK106993)
- JDRF
- American Diabetes Association
- The Immune Tolerance Network (UM1 AI09565)
- National Center for Research Resources, through Clinical Translational Science Awards (UL1TR000064, UL1TR000114, UL1TR000142, UL1TR000445, UL1TR001082, UL1TR001857, UL1TR001872, UL1TR002366, UL1TR002529, UL1TR002537)
This publication has 39 references indexed in Scilit:
- Type 1 diabetes: translating mechanistic observations into effective clinical outcomesNature Reviews Immunology, 2013
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2011
- Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trialThe Lancet, 2011
- Control of TH17 cells occurs in the small intestineNature, 2011
- T cell exhaustionNature Immunology, 2011
- Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral InfectionImmunity, 2007
- Effects of Insulin in Relatives of Patients with Type 1 Diabetes MellitusThe New England Journal of Medicine, 2002
- EPSTEIN-BARR VIRUS INFECTIONS FOLLOWING OKT3 TREATMENTTransplantation, 1989
- Discrete Sequential Boundaries for Clinical TrialsBiometrika, 1983